Status:
RECRUITING
Early Identification and Prognosis Prediction of Sepsis Through Multiomics
Lead Sponsor:
Yantai Yuhuangding Hospital
Conditions:
Sepsis
Eligibility:
All Genders
18-85 years
Brief Summary
This study aims to integrate multi-omics data and clinical indicators to reveal pathogen-specific molecular patterns in patients with sepsis and establish prognostic prediction models through multiple...
Detailed Description
This study aims to quantify the plasma metabolome, single nucleotide polymorphisms (SNPs) of exons and immunocytokines of septic patients with different pathogen infections and prognostic outcomes. Mu...
Eligibility Criteria
Inclusion
- Patients with sepsis or septic shock who meet the diagnostic criteria (2016 sepsis 3.0 standard);
- Age 18～85 years old.
Exclusion
- ICU stay of the subjects less than 72 hours;
- Female subjects who are pregnant;
- The subjects not sure if infected;
- The subjects performed CPR;
- The subjects suffer from chronic renal disease;
- The subjects with incomplete clinical data.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT05305469
Start Date
January 1 2022
End Date
December 31 2025
Last Update
January 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yantai Yuhuangding Hospital
Yantai, Shandong, China, 264000